Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T.R.U.E. TEST Panel 3.2 in Contact Dermatitis
NCT00640614Phase 3Completed
- Sponsor
- Allerderm Laboratories, Inc.
- Start
- Apr 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ethylenediamine dihydrochloride in allergic contact dermatitis (ACD), sponsored by Allerderm Laboratories, Inc.. Started Apr 2008; status: completed.
02
Drugs
ethylenediamine dihydrochloride
03
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT00640614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640614.